Alaunos Therapeutics, Inc. Common Stock (TCRT) is a publicly traded Healthcare sector company. As of August 14, 2026, TCRT trades at $1.99 with a market cap of $4.88M and a P/E ratio of -0.92. TCRT moved -1.51% today. Year to date, TCRT is -41.16%; over the trailing twelve months it is -19.58%. Its 52-week range spans $1.31 to $6.20. Rallies surfaces TCRT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TCRT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.99 |
| Market Cap | $4.88M |
| P/E Ratio | -0.92 |
| EPS | $-2.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.20 |
| 52-Week Low | $1.31 |
| Volume | 10.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.00K |
| Net Income | $-4.11M |
| Gross Margin | 0.00% |
TCRT analyst coverage data. Average price target: $0.00.